CYTEIR THERAPEUTICS, INC.

Profile

Company Names

CYTEIR THERAPEUTICS, INC.

Addresses

128 SPRING STREET, BUILDING A, SUITE 510, LEXINGTON, MA 02421

763E CONCORD AVENUE, CAMBRIDGE, MA 02138

700 MAIN STREET, CAMBRIDGE, MA 02139

Phone Numbers

857-285-4140
617-248-5239

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$111,851,302.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-02-05 
$79,999,980.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2019-09-27 
$20,200,000.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2018-01-03 
$5,833,326.00 
$35,000,000.00 
$29,166,674.00 
Equity 
1
2015-10-27 
$5,817,996.00 
$5,817,996.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
B. 
ASHER, JR. 
EXECUTIVE OFFICER
CYTEIR THERAPEUTICS, INC.
RACQUEL 
 
BRACKEN 
DIRECTOR
CYTEIR THERAPEUTICS, INC.
DONALD 
 
CORCORAN 
EXECUTIVE OFFICER, DIRECTOR
CYTEIR THERAPEUTICS, INC.
ANDREW 
 
GENGOS 
EXECUTIVE OFFICER
NEURALTUS PHARMACEUTICALS, INC.   |  CYTEIR THERAPEUTICS, INC.
JEAN 
 
GEORGE 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  ACCELERON PHARMA INC   |  CALITHERA BIOSCIENCES, INC.   |  HYDRA BIOSCIENCES INC   |  CATABASIS PHARMACEUTICALS INC   |  THRASOS INNOVATION INC.   |  GEMINI THERAPEUTICS, INC.   |  CYTEIR THERAPEUTICS, INC.
RONALD 
 
GOLDSTEIN 
EXECUTIVE OFFICER
CYTEIR THERAPEUTICS, INC.
KAREN 
 
HONG 
DIRECTOR
AGILE THERAPEUTICS INC   |  MERSANA THERAPEUTICS INC   |  PALLEON PHARMACEUTICALS INC.   |  OBSIDIAN THERAPEUTICS, INC.   |  CYTEIR THERAPEUTICS, INC.   |  STRIDEBIO, INC.
BARRY 
 
MILLS 
DIRECTOR
FLIP, LLC   |  CYTEIR THERAPEUTICS, INC.
KEVIN 
 
MILLS 
EXECUTIVE OFFICER, DIRECTOR
HOSTED DATA TRANSACTION SOLUTIONS INC.   |  CYTEIR THERAPEUTICS, INC.   |  SOCKET MOBILE, INC.
SUSAN 
 
MOLINEAUX 
DIRECTOR
CALITHERA BIOSCIENCES, INC.   |  CYTEIR THERAPEUTICS, INC.
JANWILLEM 
 
NAESENS 
DIRECTOR
FRONTIER MEDICINES CORP   |  CYTEIR THERAPEUTICS, INC.   |  AMBAGON THERAPEUTICS INC.   |  PROTEGO BIOPHARMA, INC.
MARKUS 
 
RENSCHLER 
EXECUTIVE OFFICER, DIRECTOR
CYTEIR THERAPEUTICS, INC.
TIMOTHY 
 
ROMBERGER 
DIRECTOR, EXECUTIVE OFFICER
CYTEIR THERAPEUTICS, INC.
PAUL 
 
SECRIST 
EXECUTIVE OFFICER
CYTEIR THERAPEUTICS, INC.
BART 
 
VAN HOOLAND 
DIRECTOR
CYTEIR THERAPEUTICS, INC.
JOSEPH 
S. 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ACCELERON PHARMA INC   |  INVESTABLE EMERGING MARKETS COUNTRY FUND   |  EMERGING (FREE) MARKETS COUNTRY FUND   |  GLIACURE, INC.   |  EMERGING MARKETS COUNTRY FUND   |  CERECIN INC.   |  CYTEIR THERAPEUTICS, INC.   |  AN2 THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-02-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-05 
2019-10-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-27 
2018-05-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-03 
2018-03-28
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-03 
2016-11-16
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-27 
2015-12-30
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MTS SECURITIES, LLC
104059